Is VRPX or NNN a better dividend investment in 2026?

VRPX currently yields 500000.00% with a 5% 5-year dividend growth rate. NNN yields 5.68% with 2.8% growth. The better choice depends on your goal: VRPX offers higher current income.

What is the dividend yield difference between VRPX and NNN?

VRPX has a forward dividend yield of 500000.00% ($2.00/share annually). NNN yields 5.68% ($2.38/share annually). The yield gap is 499994.32 percentage points.

Home › Compare › VRPX vs NNN

VRPX vs NNN: Dividend Comparison 2026

VRPX yields 500000.00% · NNN yields 5.68%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 VRPX wins by $4.663521010693878e+33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

VRPX

● Live price

500000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.663521010693878e+33M

Annual income

$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00

Full VRPX calculator →

NNN

NNN REIT Inc.

● Live price

5.68%

Share price

$41.89

Annual div

$2.38

5Y div CAGR

8.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.6K

Annual income

$2,637.42

Full NNN calculator →

Portfolio growth — VRPX vs NNN

📍 VRPX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VRPX	NNN
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VRPX + NNN cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VRPX pays

NNN pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VRPX

Annual income on $10K today (after 15% tax)

$42,500,000.00/yr

After 10yr DRIP, annual income (after tax)

$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr

NNN

Annual income on $10K today (after 15% tax)

$482.93/yr

After 10yr DRIP, annual income (after tax)

$2,241.81/yr

At 15% tax rate, VRPX beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VRPX + NNN for your $10,000?

VRPX: 50%NNN: 50%

100% NNN50/50100% VRPX

Portfolio after 10yr

$2.331760505346939e+33M

Annual income

$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.96%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NNN right now

VRPX

No analyst data

NNN

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$44.93

+7.3% upside vs current

Range: $43.00 — $48.50

Altman Z

1.1

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VRPX buys

NNN buys

No recent congressional trades found for VRPX or NNN in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVRPXNNN

Forward yield	500000.00% ✓	5.68%
Annual dividend / share	$2.00	$2.38 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	8.6% ✓
Portfolio after 10y	$4.663521010693878e+33M	$25.6K ✓
Annual income after 10y	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00 ✓	$2,637.42
Total dividends collected	$4.6634009849658873e+33M	$13.7K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: VRPX vs NNN ($10,000, DRIP)

Year	VRPX Portfolio	VRPX Income/yr	NNN Portfolio	NNN Income/yr	Gap
1← crossover	$50,010,700	$50,000,000.00	$10,737	$617.02	+$50.00M → VRPX
2	$233,748,371,262	$233,694,859,813.08	$11,577	$710.93	+$233748.36M → VRPX
3	$1,021,074,511,412,696	$1,020,824,400,655,446.10	$12,538	$822.59	+$1021074511.40M → VRPX
4	$4,168,597,328,794,951,700	$4,167,504,779,067,739,000.00	$13,645	$956.06	+$4168597328794.94M → VRPX
5	$15,905,475,114,600,665,000,000	$15,901,014,715,458,854,000,000.00	$14,925	$1,116.51	+$15905475114600664.00M → VRPX
6	$56,718,938,532,531,060,000,000,000	$56,701,919,674,158,435,000,000,000.00	$16,415	$1,310.57	+$56718938532531060736.00M → VRPX
7	$189,031,807,435,623,860,000,000,000,000	$188,971,118,171,394,040,000,000,000,000.00	$18,158	$1,546.77	+$1.8903180743562385e+23M → VRPX
8	$588,799,810,476,518,260,000,000,000,000,000	$588,597,546,442,562,100,000,000,000,000,000.00	$20,213	$1,836.20	+$5.8879981047651824e+26M → VRPX
9	$1,714,064,268,114,722,600,000,000,000,000,000,000	$1,713,434,252,317,512,700,000,000,000,000,000,000.00	$22,649	$2,193.37	+$1.7140642681147225e+30M → VRPX
10	$4,663,521,010,693,878,300,000,000,000,000,000,000,000	$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00	$25,558	$2,637.42	+$4.663521010693878e+33M → VRPX

VRPX vs NNN: Complete Analysis 2026

VRPX — Stock

Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company's preclinical stage product candidates also comprise PES200, which enables the delivery of a metabolically labile peptide drug into the brain; AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and VRP324, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Berwyn, Pennsylvania.

Full VRPX Calculator →

NNN — REIT

National Retail Properties invests primarily in high-quality retail properties subject generally to long-term, net leases. As of September 30, 2020, the company owned 3,114 properties in 48 states with a gross leasable area of approximately 32.4 million square feet and with a weighted average remaining lease term of 10.7 years.

Full NNN Calculator →

📬

Get this VRPX vs NNN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VRPX vs SCHD VRPX vs JEPI VRPX vs O VRPX vs KO VRPX vs MAIN VRPX vs ADC VRPX vs EPRT VRPX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.